Whoever Bids LowestThin moat

Synektik (SNT) — moat facet

For everything except the da Vinci, Synektik's rival is whoever bids lowest in the next tender.

Most of Synektik's competition takes place inside a procurement procedure. Public tenders produced 85,5% of the group's revenue in the year to September 20251, and the company's filings do not name rival distributors; they say only that, given competition in medical equipment and IT, the group cannot guarantee it will keep winning2.

Equipment orders and pipeline, nine months to June (zł m)246,0Orders 2025423,0Orders 2026137,0Active offers 2025160,8Active offers 2026Synektik interim report, nine months to June 2026
More orders and a larger pipeline.

For the da Vinci that competition is limited, because Synektik is the only source. For imaging systems, mammography, pharmacy robots and software it is open: every major manufacturer has a distributor or its own office in Poland, and the lowest compliant bid usually wins.

Synektik's defence is the pipeline. Its active offers, bids in tenders, negotiations or technical dialogue, were 160,8 million złoty at June 2026 against 137,0 million złoty a year earlier, and orders won in nine months were 423,0 million złoty, 72% more3. The win rate is not disclosed.

The pipeline moves with the calendar. Active offers were 222,4 million złoty at March 2025 and 165,3 million złoty at March 20264, and 160,8 million złoty at June 20265; a smaller pipeline after a year of record orders means offers have been converted into contracts.

Active offers are the measure. Growing while order intake keeps up would show the tenders being won at a steady rate.

Moat trajectory: Holding steady

Orders and offers both rose.

The number that tests this moat
Reported
Active offers at quarter end
160,8m zł at June 2026 (137,0m zł)

The pipeline of tenders and negotiations under way.

Source: Synektik interim report, nine months to June 2026 ↗
References
  1. ReportedPublic tenders produced 85,5% of the group's revenue in the year to September 2025, and the company's filings do not name rival distributors; they say only that, given competition in medical equipment and IT, the group cannot guarantee it will keep winning.
    Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
  2. ReportedPublic tenders produced 85,5% of the group's revenue in the year to September 2025, and the company's filings do not name rival distributors; they say only that, given competition in medical equipment and IT, the group cannot guarantee it will keep winning.
    Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
  3. ReportedIts active offers, bids in tenders, negotiations or technical dialogue, were 160,8 million złoty at June 2026 against 137,0 million złoty a year earlier, and orders won in nine months were 423,0 million złoty, 72% more.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
  4. ReportedActive offers were 222,4 million złoty at March 2025 and 165,3 million złoty at March 2026, and 160,8 million złoty at June 2026; a smaller pipeline after a year of record orders means offers have been converted into contracts.
    Synektik management board report for the half-year 1 October 2025 - 31 March 2026 - including the HistoSonics Edison exclusive distribution agreement and the installed base at March 2026. — October 2025 - March 2026 · publ. June 2026 · source ↗
  5. ReportedActive offers were 222,4 million złoty at March 2025 and 165,3 million złoty at March 2026, and 160,8 million złoty at June 2026; a smaller pipeline after a year of record orders means offers have been converted into contracts.
    Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
Sources
Generated September 24, 2026